News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Thor Halfdanarson: Serotonin as a villain and a target in small bowel NETs
Thor Halfdanarson/mayoclinic.org
Mar 7, 2025, 03:27

Thor Halfdanarson: Serotonin as a villain and a target in small bowel NETs

Thor Halfdanarson, Medical Oncologist at Mayo Clinic, shared a post on X:

“Serotonin as a villain and a target in small bowel NETs.

An excellent miniseries of talks at ENETS2025. Fibrosis, including mesenteric fibrosis, is a fascinating and challenging complication of sbNETs.

Po-Hien Ear was excellent as always!”

Thor Halfdanarson: Serotonin as a villain and a target in small bowel NETs

More posts featuring Thor Halfdanarson.

cancer ENETS2025 fight against cancer Global fight against cancer Mayo Clinic MedOnc NETs OncoDaily Oncology Po Hien Ear Thor Halfdanarson
Special Coverage
Oncolibrary
Jun 8, 2025, 17:28
ASCO 2025 Plenary Highlights: Key Practice-Changing Data Across TOP 5 ATOMIC, MATTERHORN, SERENA-6, VERIFY, and NIVOPOSTOP Trials
Blog
Jun 8, 2025, 17:04
Kimryn Rathmell Highlighted BuckeyeThon Students Raising Pediatric Blood Cancer Awareness at Farmers Market
Career
Jun 8, 2025, 17:03
Herbert Loong Joined IASLC Communications Committee For the 2025-2027 Term
Insight
Jun 8, 2025, 17:00
Christian Rolfo Highlighted VISION Trial Findings on METex14 NSCLC Detection Using Liquid and Tissue Biopsies
Blog
Jun 8, 2025, 16:58
Wafaa M Rashed: Final Words to the Eighth Cohort of the Policy Advocacy in Genetics and Genomics Course
Insight
Jun 8, 2025, 16:57
Akhil Santhosh Reflected on Experience with Dana-Farber’s Breast Oncology Team Through ASCO IDEA Program
Insight
Jun 8, 2025, 16:55
Al-Ola Abdallah Shared 2025 MIDAS Trial on MRD-Guided Myeloma Therapy Published in NEJM
Insight
Jun 8, 2025, 16:53
Talha Badar Shared an Article Published in Blood, ASH Journal
Insight
Jun 8, 2025, 16:48
Arndt Vogel Highlighted Phase II PANACHE01 Trial on Neoadjuvant FOLF(IRIN)OX for Resectable PDAC
Insight
Jun 8, 2025, 16:46
Giannis Mountzios Highlighted ASCO25 DeLLphi-304 Trial Featuring Tarlatamab Progress
Blog
Jun 8, 2025, 16:44
Mohammad Jad Moussa Joined 2025 KCA 81K Challenge for Kidney Cancer Awareness
Insight
Jun 8, 2025, 16:42
Rami Manochakian Highlighted ASCO Connection Article on Building a Career in Oncology Medical Education